Haemostasis Tiffany Shaw MBChB II 2002. Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.

Slides:



Advertisements
Similar presentations
Coagulation: Review & Lab techniques
Advertisements

Chapter 12 Disorders of Hemostasis
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
Bleeding disorders Doc. MUDr. L. Boudová, Ph.D.. Bleeding disorders I. Vessels - increased fragility II. Platelets - deficiency or dysfunction III.Coagulation.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
HEMOSTASIS Hemostasis
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Vascular Pharmacology
Anatomy and Physiology 3/15 and 3/16
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
MLAB 1227: Coagulation Keri Brophy-Martinez
Disseminated intravascular coagulation (DIC)
Approach to the Bleeding Patient
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Asilmi HEMOSTASIS Ahmad Shihada Silmi Faculty of Sciences IUG Med. Tech. Dep. Room # B326.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
Blood Course By Dr. Khidir Abdel Galil.
HEMOSTASis Nada Mohamed Ahmed , MD, MT (ASCP)i.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Blood disorders.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Hemostasis and Blood Coagulation
FUNCTIONS OF THE COAGULATION SYSTEM ACTIONDESIRED RESULT Rapid formation of mechanically sound clot Stop bleeding quickly Prevent clot formation at non-injured.
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
Bleeding Disorders Dr. Farjah H.AlGahtani
Approach to Bleeding Disorders
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
Hemostasis. Hemostasis Definition Prevention of blood loss (stoppage of blood flow)
Hemostasis & blood coagulation Dr. Wasif Haq. Hemostasis Hemostasis: prevention of blood loss. Is hemostasis same as homeostasis?
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
Bleeding Disorders JANUARY 19, 2012 Erin M. Kwolek.
Investigation of Haemostasis MS. c. program Lab-9.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
PLATELETS (PLTs) or Thrombocytes Dr. Taj Platelets Thrombocytes are Fragments of megakaryocytes in bone marrow.
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
Von Willebrand Disease
Hemostasis and Coagulation Hemostasis Hemostasis is the maintenance of circulating blood in the liquid state and retention of blood in the vascular system.
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 26 Disorders of Hemostasis.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Coagulation tests CBC- complete blood count
Chapter 23. Bleeding disorders associated with coagulopathy
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Bleeding disorders due to vascular & platelets abnormalities
Immune thrombocytopenia purpura(ITP)
Haematology.
2nd Year Medicine- Blood Module May 2008
Acquired coagulation disorders
Platelets disorders.
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Constituents of the blood: Platelets and plasma
and anti-thrombotic pharmocology Tom Williams
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Intra vascular anti-coagulants
The Fascinating World of Haemostasis and Thrombosis
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
Dr. Ahmed Hassaneen Coagulation disorders.
Hemostasis and Coagulation
Presentation transcript:

Haemostasis Tiffany Shaw MBChB II 2002

Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction Platelet aggregation Fibrin Primary haemostatic plug Secondary haemostatic plug

Coagulation Cascade

Integrity of Haemostasis Depends on: 1.Vessel wall 2.Platelets (no. and function) 3.Coagulation factors

Vessel Wall Release tissue factor that initiates coagulation cascade. Exposed collagen results in platelet adhesion (using vWF as a bridge). Hereditary haemorrhagic telangiectasia Scurvy Senile purpura

Hereditary Haemorrhagic Telangiectasia

Low Platelet Number N = 150 – 450 Excessive bleed / Spontaneous bleed Mucosal surfaces / Skin Immune Mediated Thrombocytopenia Drug induced Haemolytic Uraemic Syndrome DIC

Platelet Dysfunction Abnormal platelet aggregation Normal platelet count Excessive / spontaneous bleed Mucosa / Skin Inherited disorders Drug induced

Eccymoses

Coagulation Factors Deficiency Spontaneous bleeding into deep tissues Increased post-traumatic haemorrhage Factor 8 – Haemophilia A Factor 9 – Haemophilia B vWF – Von Willebrand’s disease Von Willebrand’s Factor: Protein produced by endothelial cells which mediates platelet adhesion to endothelium and carries factor 8 in plasma.

Haemaphilia A Factor 8 deficiency 50 / million people Sex-linked Most detected in childhood Mild symptoms ~ spontaneous bleed Chronic joint disease after repeated bleed

Haemophilia B Factor 9 deficiency = Christmas disease Also sex-linked Similar presentation as haemophilia A Much rare

Haemoarthroses

Von Willebrand’s Disease vWF deficiency Autosomal dominant (F = M) Most common inherited bleeding disorder Bleeding from mucosa Excessive blood loss in trauma Bleeding into deep tissue (rarer)

Liver Disease Mixed – both coag deficiency and platelet problem Reduced coag factor synthesis (1, 2, 5, 7, 9, 10) Cirrhosis  Hypersplenism  Thrombocytopenia

DIC Generalised activation of coag cascade Wide-spread fibrin formation Thrombosis Low coag factor Bleeding

DIC Consequence of Thrombosis: 1.Tissue infarction  Renal impairment 2.CVA 3.PE 4.DVT Consequence of Bleeding: 1.Purpura 2.GI Bleed

DIC Causes of coag cascade activation: 1.Sepsis 2.Disseminated cancer 3.Obstetric complications (e.g. retained product of conception) 4.Fulminant liver disease 5.Anaphylaxis 6.AML

Drug Induced Coag Factor Def Heparin: Inactivates certain coag factors (e.g. 9a, 10a, 11a, 2) Also impairs platelet function Warfarin: Block synthesis of Vit K dependent factors (2, 7, 9, 10)

Other Disorders Vitamin K deficiency Autoantibodies to coag factors Haemorrhagic disease of the newborn Massive transfusion

Investigations for Bleeding 1.Platelet Count 2.Bleeding time 3.Activated Partial Thromboplastin Time 4.Prothrombin Time (INR) 5.Plasma level assay

Investigations for Bleeding ConditionTest Wall DefectAll tests are normal. Low PlateletLow platelet count + bleeding time Platelet DysfNormal platelet count + bleeding time Haemophilia APPT + Plasma level vWD APPT + bleeding time + plasma level Liver Disease INR + APPT + platelet count Drug Induced INR + APPT + plasma level DICAll tests are abnormal.

Management 1.Replace deficiency 2.Treat underlying cause 3.Reversal of drug effects 4.Supportive therapy

Extra Notes on ITP Platelets become coated by autoantibodies Removed by RES  reduced lifespan Low platelet count Acute / Chronic Purpura / Spontaneous bleed / Asymptomatic May resolve spontaneously or require medical treatment

Extra Notes on ITP Isolated low platelet count < 20 Increased megakaryocytes in bone marrow Normal INR + APPT Increased bleeding time

Extra Notes on ITP Mx: 1.Do nothing 2.Prednisolone 3.Splenectomy 4.Other immunosuppresives

Extra Notes on IPT May be associated with: Haematological malignancies Viral infections (e.g. HIV) C.T. disorders (e.g. SLE)  Test for c.t. disorders.

70-Year-Old with ITP Incidental finding in 1993 Platelet count = 60 Asymptomatic Referred to haematologist Test for c.t. disorders U/S for spleen size Bone marrow biopsy

70-Year-Old with ITP Negative for c.t. disorders Spleen size normal Bone marrow: increased megakaryoccytes Continue monitoring (weekly FBC)

70-Year-Old with ITP December 1993 Bruising with minimal trauma Platelet count = 43 Start Prednisolone After 6/52  platelet count 190 Slowly dropped again after withdrawal Asymptomatic

70-Year-Old with ITP Continue monitoring Platelet transfusion if serious bleeding occurs Consider splenectomy if worsens Discharged to GP last week